Dr. Julie Vose Discusses CAR T-Cell Therapy

Name: Dr. Julie Vose Discusses CAR T-Cell Therapy
Uploaded: 2017-06-19T16:50:30-04:00
Description: A promising therapy for people with recurring non-Hodgkin’s lymphoma and acute lymphoblastic leukemia is providing new hope. Nebraska Medicine is one of a few centers in the country providing Chimeric Antigen Receptor (CAR) T-Cell Therapy. To find out if you are a candidate for the CAR T-Cell Therapy clinical trial, please call 402.559.5600.

Dr. Julie Vose Discusses CAR T-Cell Therapy

Dr. Julie Vose Discusses CAR T-Cell Therapy and the Fred & Pamela Buffett Cancer Center